BOSTON, MA, Telecardia, a Boston-based developer of pH sensing technology, has raised $1.5 million in a venture capital deal, according to a filing by the company with the Securities and Exchange Commission. The filing noted two separate investors in the round.

Telecardia, Inc. is a technology development company with a series of disruptive, proprietary and versatile MEMS enabled pH sensortechnology platforms. AccuMET™ pH sensing platforms include a Single Measurement Chip (SMC) designed for discrete single measurements, as well as Multiple Measurement Chip (MMC). There is also, a Continuous Self-Calibrating chip (CSC),which is designed for use in continuous monitoring applications, and the CSCxt, which is designed for long-term continuous monitoring (10 years or more).